Diabetic retinopathy (DR) is the most common microangiopathic complication of diabetes
mellitus, representing a major cause of visual impairment in developed countries …

Background Diabetic macular oedema (DMO) is a common complication of diabetic
retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk …

Introduction Diabetic retinopathy (DR) is one of the most frequent microvascular
complications of diabetes that can lead to blindness. Laser treatment has been the gold …

Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite
that DME represents a sight‐threatening condition, it is also among the most accessible to …

Diabetic retinopathy (DR) is the leading cause of vision impairment in the global working‐
age population. In China, with one‐third of the world's diabetes population estimated at 141 …

Importance Systemic safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF)
is a matter of debate and regular updates are necessary. Objective To evaluate systemic …

Introduction A systematic literature review (SLR) and network meta-analysis (NMA) were
conducted to evaluate the comparative efficacy, durability and safety of faricimab, used in a …

Macular edema (ME) is associated with various conditions; however, the main causes of ME
are retinal vein occlusion (RVO) and diabetes. Laser photocoagulation, formerly the gold …

Purpose: To assess the 1-year efficacy, durability, and safety of faricimab in patients with
diabetic macular edema from Asian and non-Asian countries. Design: Global, multicenter …

Purpose This meta-analysis aims to summarize 12-month best-corrected visual acuity
(BCVA) outcomes in response to anti-vascular endothelial growth factor (VEGF) therapy and …